KERA anticorps (AA 21-352)
Aperçu rapide pour KERA anticorps (AA 21-352) (ABIN7157472)
Antigène
Voir toutes KERA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 21-352
-
Réactivité croisée
- Humain
-
Purification
- Antigen Affinity Purified
-
Immunogène
- Recombinant Human Keratocan protein (21-352AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- KERA (Keratocan (KERA))
-
Autre désignation
- KERA
-
Sujet
-
Background: May be important in developing and maintaining corneal transparency and for the structure of the stromal matrix.
Aliases: CNA2 antibody, KERA antibody, KERA_HUMAN antibody, Keratan sulfate proteoglycan keratocan antibody, Keratocan antibody, KTN antibody, SLRR2B antibody
-
UniProt
- O60938
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-